|

Allogeneic Natural Killer Cell Line NK-92 Clinical Trials

1 actively recruiting trial across 1 location

Also known as: NK-92, NK-92 Cells, haNK

Pipeline

Phase 2: 1

Top Sponsors

  • M.D. Anderson Cancer Center1

Indications

  • Therapy-Related Myelodysplastic Syndrome1
  • Myelodysplastic Syndrome With Gene Mutation1
  • ISS Stage III Plasma Cell Myeloma1
  • ISS Stage II Plasma Cell Myeloma1
  • Acute Myeloid Leukemia With Variant MLL Translocations1

Houston, Texas1 trial

Personalized NK Cell Therapy in CBT

M D Anderson Cancer Center

Phase 2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.